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Waddlia chondrophila: From
Bovine Abortion to Human
Miscarriage
To the Editor—Miscarriage is the
most common complication of preg-
nancy, affecting every fourth woman
during her life [1]. Despite thorough
investigations, an etiology is elucidated
in only 50% of cases. A recent serological
study has suggested a role of Waddlia
chondrophila, a strict intracellular bac-
teria belonging to the Chlamydiales or-
der, in human miscarriage [2]. Thus, 96
out of 438 women exhibited an anti-
Waddlia immunoglobulin G (IgG) titer
R1:64. This seroprevalence was signifi-
cantly higher in patients with mis-
carriage (32%) compared with control
women with an uneventful pregnancy
(7%, P , .001). Anti-Waddlia anti-
bodies were specific, as they did not
cross-react with antibodies directed
against other Chlamydiaceae (ie, Chla-
mydia trachomatis, Chlamydia pneumo-
niae, or Chlamydia psittaci) or other
intracellular bacteria such as Rickettsia,
Coxiella, Wolbachia, and Anaplasma
[2–4]. Moreover, the strong statistical
association between miscarriage and IgG
reactivity against Waddlia remained
when adjusted for possible confounding
factors in various multivariate logistic
regression models [2]. However, direct
demonstration of Waddlia in human
placenta has not yet been reported. We
thus investigated the role of Waddlia in
human miscarriage prospectively as part
of an ongoing study. This study has been
approved by the local ethical committee
(reference number 138/06). We herein
document the first case of Waddlia-
associated miscarriage by demonstrating
the direct presence of Waddlia in the
cervicovaginal secretion and in the
placenta by polymerase chain reaction
(PCR) and immunohistochemistry.
After a normal pregnancy and a first
early miscarriage, a 34-year-old white
woman presented with a second mis-
carriage at week 10 of gestation. The
patient did not report any prior medical
or surgical history. She neither had pets
nor contact with animals, and she did
not live in a rural area. The patient
underwent a dilatation and curettage,
during which retained products of con-
ception, serum, and cervicovaginal swab
were collected. Postoperative follow-up
was uneventful.
Immunofluorescence was performed
as previously described [2] and showed
a positive anti-Waddlia antibody sero-
logy (titer 1:64). In addition, DNA of
Waddlia was amplified from the cervi-
covaginal swab using a Waddlia specific
real-time PCR [5]. The patient had
neither Chlamydia trachomatis–positive
serology nor DNA in the cervicovaginal
swab. Placental histology showed the
presence of numerous polymorpho-
nuclear cells in the fibrin of the de-
cidua, compatible with an early infection
(Figure 1A). Moreover, Waddlia immu-
nohistochemistry showed the presence
of Waddlia infected cells localised in
the glandular epithelium (Figures 1B, C,
and D).
We thus show here strong evidence
of human infection with Waddlia
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chondrophila. Indeed, Waddlia infection
was documented by serology, by PCR,
and by immunohistochemistry. The lat-
ter test confirmed the presence of
Waddlia in the placenta, in an area ex-
hibiting signs of recent infection.
Animals are an important infection
source and reservoir of emerging human
pathogens. Waddlia was first identified in
bovine abortion [1, 3, 4]. Other zoonotic
pathogens, such as Toxoplasma goondii,
Chlamydophila abortus, and Coxiella
burnetti are well-known agents of adverse
human pregnancy outcomes. Whether
human infection with Waddlia occurs
through contact with animals is still
questionable. In this case, the patient did
not have any contact with animals. But
transmission might also occur through
ingestion of contaminated milk or meat.
Since Waddlia has also been recovered
in the vaginal and respiratory tract area
of humans [5], human-to-human trans-
mission is also possible. The high
Waddlia seroprevalence in women suffer-
ing from miscarriage [2] makes further
investigations urgently necessary to ex-
plore the role of Waddlia in this setting.
This first report of Waddlia in miscarriage
might give new insight in the prevention
and investigation of miscarriage, the most
frequent complication of human preg-
nancy.
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Figure 1. Histological Pictures and Immunohistochemistry to Detect Waddlia chondrophila. (A),
Hematoxylineosin–stained histological sections of the placenta (magnification 3200). (B, C, and
D) Immunohistochemistry (magnification 3200 for B, 3400 for C and D) using a specific rabbit
polyclonal antibody (dilution of 1:12,000) to investigate for the presence of Waddlia in the
placenta. Detection was performed with the Dako ChemMate Detection Kit according to the
manufacturer's instructions. The histological picture (A) shows infiltration of the placenta with
numerous polymorphonuclear cells compatible with early infection. Immunohistochemistry (B, C,
and D) demonstrated the presence of Waddlia in epithelial cells of the endometrial glands.
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